JP Patent

JP7352841B2 — ３－（イミダゾ［１，２－ｂ］ピリダジン－３－イルエチニル）－４－メチル－Ｎ－｛４－［（４－メチルピペラジン－１－イル）メチル］－３－（トリフルオロメチル）フェニル｝ベンズアミドおよびその一塩酸塩の結晶形

Assigned to アリアド・ファーマシューティカルズ・インコーポレイテッド · Expires 2023-09-29 · 3y expired

What this patent protects

Patent listed against ponatinib-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
JP7352841B2
Jurisdiction
JP
Classification
—
Expires
2023-09-29
Drug substance claim
No
Drug product claim
No
Assignee
アリアド・ファーマシューティカルズ・インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.